Colin Sandercock, SVP, General Counsel and Secretary at Cue Biopharma, Inc. (CUE), bought 16,938 shares at $7.10 ($133K) on 2019-06-06, disclosed to the SEC on 2019-06-10.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.10 | 2,000 | $14K | 10.7% |
| 2 | $7.93 | 14,938 | $118K | 89.3% |
| Total | $7.83 avg | 16,938 | $133K | 100% |
| Filing → |
| CUE | BUY | 2020-02-24 | $238K | — | Filing → |